FIELD: chemistry.
SUBSTANCE: invention relates to novel derivatives of 1-(2-chloroquinolin-3-yl)-4-dimethylamino-2-(naphthalen-1-yl)-1-phenylbutan-2-ol of general formula I 
or their pharmaceutically acceptable salts with acids, where R1 denotes H, R2+R3 denotes -O-(CH2)n-O-, where n=1-2, which forms additional dioxane and 1,3-dioxolane rings. The invention also relates to a method of producing a compound of formula I and to use of the compound of formula I in treating infectious mycobacterial diseases.
EFFECT: obtaining novel compounds with useful biological activity.
4 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| QUINOLINE DERIVATIVES, PARTICULARLY 5,6,7-SUBSTITUTED 1-(2-CHLOROQUINOLIN-3-YL)-4-DIMETHYLAMINO-2-(NAPHTHALEN-1-YL)-1-PHENYLBUTAN-2-OLES, METHOD FOR PREPARING AND USING COMPOUNDS | 2011 |
|
RU2486175C2 |
| NOVEL QUINOLINE DERIVATIVES, SYNTHESIS METHOD THEREOF, USE THEREOF IN TREATING MYCOBACTERIAL INFECTIONS, PHARMACEUTICAL COMPOSITION BASED ON SAID DERIVATIVES | 2008 |
|
RU2404971C2 |
| SELECTIVE ANTI-TUBERCULOSIS AGENTS, REPRESENTING 3-AMINOSUBSTITUTED 6-(3,5-DIMETHYLPYRAZOL-1-YL)-1,2,4,5-TETRAZINES | 2012 |
|
RU2519218C2 |
| QUATERNARY AMMONIUM DERIVATIVES OF 2-AMINOTHIOPHEN-3-CARBOXYLATES HAVING ANTI-TUBERCULOSIS ACTIVITY | 2016 |
|
RU2629369C1 |
| (4-(3-HYDROXYPHENYL)PIPERAZINE-1-YL)(5-NITROFURAN-2-YL)METHANON, WHICH HAS ANTITUBERCULAR ACTIVITY AGAINST THE CAUSATIVE AGENT OF MULTIDRUG-RESISTANT TUBERCULOSIS, AND THE METHOD FOR ITS PREPARATION | 2021 |
|
RU2784399C1 |
| DIALKYL(2-METHYL-4-OXOPENT-2-YL)PHOSPHINE OXIDE PYRIDINOYL HYDRAZONES, HAVING ANTITUBERCULOUS ACTIVITY | 2012 |
|
RU2498990C1 |
| PHENYL FORMAMIDINE DERIVATIVES, HAVING ANTIMYCOBACTERIAL ACTIVITY | 2018 |
|
RU2702224C2 |
| 1-ETHYL-6-FLUORO-4-OXO-7-(8-ETHOXY-2-OXO-2H-CHROMEN-3-YL)-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID WITH ANTI-TUBERCULAR ACTIVITY | 2017 |
|
RU2642426C1 |
| METHOD FOR PRODUCING (1R,2S)-1-(6-BROMO-2-METHOXYQUINOLINE-3-YL)-4-DIMETHYLAMINO-2-(1-NAPHTHYL)-1-PHENYLBUTANE-2-OL AND A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF | 2021 |
|
RU2780560C1 |
| ANTIBACTERIAL QUINOLINE DERIVATIVES | 2007 |
|
RU2446159C2 |
